261 related articles for article (PubMed ID: 25462536)
1. Detection of drug specific circulating immune complexes from in vivo cynomolgus monkey serum samples.
Pierog P; Krishna M; Yamniuk A; Chauhan A; DeSilva B
J Immunol Methods; 2015 Jan; 416():124-36. PubMed ID: 25462536
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
[TBL] [Abstract][Full Text] [Related]
3. A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays.
Zoghbi J; Xu Y; Grabert R; Theobald V; Richards S
J Immunol Methods; 2015 Nov; 426():62-9. PubMed ID: 26255760
[TBL] [Abstract][Full Text] [Related]
4. Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry.
Li J; Schantz A; Schwegler M; Shankar G
J Pharm Biomed Anal; 2011 Jan; 54(2):286-94. PubMed ID: 20869832
[TBL] [Abstract][Full Text] [Related]
5. Epitope characterization of the ADA response directed against a targeted immunocytokine.
Stubenrauch K; Künzel C; Vogel R; Tuerck D; Schick E; Heinrich J
J Pharm Biomed Anal; 2015 Oct; 114():296-304. PubMed ID: 26093509
[TBL] [Abstract][Full Text] [Related]
6. The impact of immunogenicity on therapeutic antibody pharmacokinetics: A preclinical evaluation of the effect of immune complex formation and antibody effector function on clearance.
Opolka-Hoffmann E; Jordan G; Otteneder M; Kieferle R; Lechmann M; Winter G; Staack RF
MAbs; 2021; 13(1):1995929. PubMed ID: 34763611
[TBL] [Abstract][Full Text] [Related]
7. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies.
Wang SJ; Wu ST; Gokemeijer J; Fura A; Krishna M; Morin P; Chen G; Price K; Wang-Iverson D; Olah T; Weiner R; Tymiak A; Jemal M
Anal Bioanal Chem; 2012 Jan; 402(3):1229-39. PubMed ID: 22130720
[TBL] [Abstract][Full Text] [Related]
8. Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates.
Birmingham DJ; Hebert LA; Cosio FG; VanAman ME
J Lab Clin Med; 1990 Aug; 116(2):242-52. PubMed ID: 1697615
[TBL] [Abstract][Full Text] [Related]
9. Application of a Plug-and-Play Immunogenicity Assay in Cynomolgus Monkey Serum for ADCs at Early Stages of Drug Development.
Carrasco-Triguero M; Davis H; Zhu Y; Coleman D; Nazzal D; Vu P; Kaur S
J Immunol Res; 2016; 2016():2618575. PubMed ID: 27092313
[TBL] [Abstract][Full Text] [Related]
10. Restricted immune activation and internalisation of anti-idiotype complexes between drug and antidrug antibodies.
van Schie KA; Kruithof S; Ooijevaar-de Heer P; Derksen NIL; van de Bovenkamp FS; Saris A; Vidarsson G; Bentlage AEH; Jiskoot W; Romeijn S; Koning RI; Bos E; Stork EM; Koeleman CAM; Wuhrer M; Wolbink G; Rispens T
Ann Rheum Dis; 2018 Oct; 77(10):1471-1479. PubMed ID: 29945923
[TBL] [Abstract][Full Text] [Related]
11. Quantification of a bifunctional drug in the presence of an immune response: a ligand-binding assay specific for 'active' drug.
Staack RF; Jordan G; Viert M; Schäfer M; Papadimitriou A; Heinrich J
Bioanalysis; 2015 Dec; 7(24):3097-106. PubMed ID: 26484402
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity screening assay development for a novel human-mouse chimeric anti-CD147 monoclonal antibody (Metuzumab).
Mi L; Li W; Li M; Chen T; Wang M; Sun L; Chen Z
J Immunol Methods; 2016 Jun; 433():38-43. PubMed ID: 26944771
[TBL] [Abstract][Full Text] [Related]
13. A novel method for the detection of antibodies to adalimumab in the presence of drug reveals "hidden" immunogenicity in rheumatoid arthritis patients.
van Schouwenburg PA; Bartelds GM; Hart MH; Aarden L; Wolbink GJ; Wouters D
J Immunol Methods; 2010 Oct; 362(1-2):82-8. PubMed ID: 20833178
[TBL] [Abstract][Full Text] [Related]
14. Generation, Characterization, and Quantitative Bioanalysis of Drug/Anti-drug Antibody Immune Complexes to Facilitate Dedicated In Vivo Studies.
Hoffmann E; Jordan G; Lauer M; Ringler P; Kusznir EA; Rufer AC; Huber S; Jochner A; Winter G; Staack RF
Pharm Res; 2019 Jun; 36(9):129. PubMed ID: 31254106
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and immunogenicity investigation of a human anti-interleukin-17 monoclonal antibody in non-naïve cynomolgus monkeys.
Han C; Gunn GR; Marini JC; Shankar G; Han Hsu H; Davis HM
Drug Metab Dispos; 2015 May; 43(5):762-70. PubMed ID: 25739974
[TBL] [Abstract][Full Text] [Related]
16. Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA.
Smith HW; Butterfield A; Sun D
Regul Toxicol Pharmacol; 2007 Dec; 49(3):230-7. PubMed ID: 17869396
[TBL] [Abstract][Full Text] [Related]
17. A method combining blue native polyacrylamide gel electrophoresis with liquid chromatography tandem-mass spectrometry to detect circulating immune complexes between therapeutic monoclonal antibodies and anti-drug antibodies in animals.
Kobayashi K; Tahara H; Kagawa Y
J Pharm Biomed Anal; 2020 Jul; 186():113329. PubMed ID: 32371323
[TBL] [Abstract][Full Text] [Related]
18. SEC Based Method for Size Determination of Immune Complexes of Therapeutic Antibodies in Animal Matrix.
Boysen M; Schlicksupp L; Dreher I; Loebbert R; Richter M
J Immunol Res; 2016; 2016():9096059. PubMed ID: 27556050
[TBL] [Abstract][Full Text] [Related]
19. Detection of antidrug antibodies against human therapeutic antibodies lacking Fc-effector functions by usage of soluble Fcγ receptor I.
Wessels U; Poehler A; Moheysen-Zadeh M; Zadak M; Staack RF; Umana P; Heinrich J; Stubenrauch K
Bioanalysis; 2016 Oct; 8(20):2135-45. PubMed ID: 27582032
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of TNF-Inhibitors.
Atiqi S; Hooijberg F; Loeff FC; Rispens T; Wolbink GJ
Front Immunol; 2020; 11():312. PubMed ID: 32174918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
